Identification | Back Directory | [Name]
7-Bromo-3,4-dihydro-1H-quinolin-2-one | [CAS]
14548-51-7 | [Synonyms]
7-Bromo-3,4-dihydro-1H-quinolin-2-one 7-broMo-3,4-dihydroquinolin-2(1H)-one 2(1H)-Quinolinone, 7-bromo-3,4-dihydro- 7-BROMO-1,2,3,4-TETRAHYDRO-2-QUINOLINONE 7-BROMO-3,4-DIHYDRO-1H-QUINOLIN-2-ONE 1G | [Molecular Formula]
C9H8BrNO | [MDL Number]
MFCD09878790 | [MOL File]
14548-51-7.mol | [Molecular Weight]
226.07 |
Chemical Properties | Back Directory | [Boiling point ]
359.1±42.0 °C(Predicted) | [density ]
1.559±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
14.08±0.20(Predicted) | [Appearance]
White to light yellow Solid |
Hazard Information | Back Directory | [Synthesis]
6-Bromo-2,3-dihydro-1H-inden-1-one (2.0 g, 9.5 mmol) was used as starting material and dissolved in chloroform (30 mL). Under stirring, methanesulfonic acid (6 mL) was slowly added dropwise to the reaction system. Subsequently, sodium azide (1.90 g, 9.5 mmol) was added in batches, and after addition, the reaction mixture was heated to reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature and carefully poured into ice water. The aqueous phase was extracted with dichloromethane, the organic phases were combined and dried over anhydrous sodium sulfate. After filtration, the solvent was removed by concentration under reduced pressure to give the crude product. The crude product was purified by column chromatography (eluent: petroleum ether/ethyl acetate=2/1) to afford the target compound 7-bromo-3,4-dihydroquinolin-2(1H)-one (0.90 g) in 42% yield. | [References]
[1] Patent: CN106349241, 2017, A. Location in patent: Paragraph 0538; 0539; 0540; 0541; 0542 [2] Patent: WO2010/38901, 2010, A1. Location in patent: Page/Page column 44 [3] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 6, p. 662 - 667 |
|
|